Putnam Investments’s HTG Molecular Diagnostics, Inc. Common Stock HTGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-5,845
| Closed | -$2.67M | – | 1002 |
|
|
2018
Q4 | $2.67M | Hold |
5,845
| – | – | 0.01% | 586 |
|
|
2018
Q3 | $5.31M | Sell |
5,845
-1,865
| -24% | -$1.7M | 0.01% | 551 |
|
|
2018
Q2 | $4.52M | Buy |
7,710
+1,842
| +31% | +$1.08M | 0.01% | 556 |
|
|
2018
Q1 | $3.82M | Buy |
5,868
+5,556
| +1,781% | +$3.62M | 0.01% | 565 |
|
|
2017
Q4 | $114K | Hold |
312
| – | – | ﹤0.01% | 1069 |
|
|
2017
Q3 | $96K | Sell |
312
-1
| -0.3% | -$308 | ﹤0.01% | 1098 |
|
|
2017
Q2 | $150K | Sell |
313
-2,749
| -90% | -$1.32M | ﹤0.01% | 1090 |
|
|
2017
Q1 | $3.82M | Sell |
3,062
-111
| -3% | -$138K | 0.01% | 704 |
|
|
2016
Q4 | $1.28M | Hold |
3,173
| – | – | ﹤0.01% | 948 |
|
|
2016
Q3 | $1.33M | Sell |
3,173
-15
| -0.5% | -$6.26K | ﹤0.01% | 953 |
|
|
2016
Q2 | $1.49M | Buy |
3,188
+1
| +0% | +$468 | ﹤0.01% | 1014 |
|
|
2016
Q1 | $1.65M | Sell |
3,187
-11
| -0.3% | -$5.69K | ﹤0.01% | 995 |
|
|
2015
Q4 | $2.51M | Hold |
3,198
| – | – | 0.01% | 914 |
|
|
2015
Q3 | $4.39M | Buy |
3,198
+631
| +25% | +$865K | 0.01% | 714 |
|
|
2015
Q2 | $5.15M | Buy |
+2,567
| New | +$5.15M | 0.01% | 716 |
|